Developing new nanoparticles for treating muscle disorders
A novel framework for nanomedicine development
['FUNDING_OTHER'] · UNIVERSITY OF OKLAHOMA · NIH-10896232
This study is all about developing tiny particles that can safely carry medicines and genetic materials directly to muscle cells, helping to improve treatments for people with muscle disorders.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF OKLAHOMA (nih funded) |
| Locations | 1 site (NORMAN, UNITED STATES) |
| Trial ID | NIH-10896232 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative nanoparticles that can safely and effectively deliver drugs and genetic materials to skeletal muscle cells. The team will explore new methods for tracking how these nanoparticles move within biological systems, ensuring they reach their intended targets. By improving the delivery mechanisms, the research aims to enhance the treatment options available for patients with muscle disorders. The ultimate goal is to make significant advancements in nanomedicine that can lead to better therapies for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with skeletal muscle disorders who may benefit from advanced therapeutic options.
Not a fit: Patients with non-muscle related conditions or those who do not have access to the required treatment facilities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from muscle disorders.
How similar studies have performed: Previous research in nanomedicine has shown promising results in improving drug delivery systems, indicating potential success for this novel approach.
Where this research is happening
NORMAN, UNITED STATES
- UNIVERSITY OF OKLAHOMA — NORMAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILHELM, STEFAN — UNIVERSITY OF OKLAHOMA
- Study coordinator: WILHELM, STEFAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Muscle Disease